Professor Gregory TANNOCK


Casual Academic

School /
Work Unit

School of Science

Contact Details

No Phone


City campus


Science, Engineering and Health

"Professor Greg Tannock"Summary of responsibilities

  • Responsible for the delivery of undergraduate and Graduate Diploma courses in Virology to most departments within the Faculty of Life Sciences.
  • Currently supervising five PhD and one Honours students.
  • Director of the Vaccine Evaluation Unit for the clinical assessment of human Influenza vaccines and of the Marek’s Disease Vaccine Assay Unit for assessing the potency of vaccines against Marek’s disease, a highly significant tumour virus of chickens. Both activities are accredited by the National Asscociation of Testing Authorities.
  • Member of three government committees concerned with influenza and the importation of eggs and egg products.
  • Recipient of grants of approximately $450,000 p.a. in 2003 from industry and the Rural Industries Research and Development Corporation.
  • Member of Collaborative Research Centres for the Chicken Industry and Microtechnology.


Bachelor of Science, University of West Australia, 1960,

Master of Science, University of West Australia, 1966

Doctor of Philosophy (PhD), Australian National University, 1970

Doctor of Science, University of Newcastle, (Australia), 1996.

Fellow of the Australian Society for Microbiology, 2002.

Teaching responsibilities

  • Responsible for the delivery of lectures and for the development of courses in Virology at undergraduate level to most departments of the Faculty of Life Sciences, and for the design, organization and delivery of Post-Graduate Diploma courses in Viral Infections and Veterinary Microbiology.
  • Current Principal Supervisor to five PhD and one Honours student.
  • Principal Supervisor in five completed PhD and five Honours candidates over the past five years.

Industry / profession / community involvement

  • Fellow of the Australian Society for Microbiology.
  • Member of the Australian Veterinary Poultry Association.
  • Member of the Australian Influenza Vaccine Committee of the Therapeutics Goods Administration.
  • Member of the Influenza National Pandemic Planning Committee of the Commonwealth Department of Health and Aging.
  • Member of the Risk Assessment Committee for the Egg Industry for the Rural Industries Research and Development Corporation.
  • Member of the Editorial Board of The Journal of Medical Virology (2001-), Gene Vaccines and Therapy (2002-).

Research publications

Ada, G.L., Tannock, G.A. and Hampson, A.W. (1997).Conference report.Options for the Control of Influenza III.Cairns, May 1996.Vaccine 15: 245-47.

Romanova, J.R., Tannock, G.A. and Alexandrova, G.I. (1997).Protective responses in mice to vaccination with multiply administered strains of cold-adapted live influenza vaccines and wild-type viruses.Vaccine 15: 653-58.

DeLaney, D.B., Morrow, C.J., Read, K.M. and Tannock, G.A. (1998).The development and evaluation of two tissue culture grown Marek’s disease challenge viruses.Avian Pathology 27: 472-77.

Jaikumar, D. and Tannock, G.A. (2001).Adaptation of Marek’s disease virus to the Vero continuous cell line.VeterinaryMicrobiology 79: 75-82.

Wareing, M.D., Watson, J.M., Brooks, M.J. and Tannock, G.A. (2001).Immunogenic and isotype-specific responses to Russian and US influenza A cold-adapted donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57 and A/Ann Arbor/6/60 (H2N2) in mice.Journal of Medical Virology 65: 171-77.

Wareing, M.D. and Tannock, G.A. (2001).Live attenuated vaccines against influenza; an historical review.Vaccine: 19: 3320-30.

Cunningham, S.C., Lew, A.M. and Tannock, G.A. (2001).The antigenicity of the chicken anaemia virus protein VP3 (apoptin).Avian Pathology: 30: 613-19.

Walkden-Brown, S.W., Islam, A.F.M.F., Burgess, S.K., Wong, C.W., Groves, P.J., Young, P.L., Cipriani, T.L., Mastorakos, Z. and Tannock, G.A. (2001).Comparison of PCR and virus isolation for detection of MDV viremia following artificial and natural challenge in broiler chicks with homologous antibody.In Current Progress in Marek’s Disease Research.Eds. K.A. Schat et al.American Association of Avian Pathologists, 383 West Street Road, Kennett Square PA, USA, pp 59-62.

Karpathy, R.C., Firth, G.A. and Tannock, G.A. (2002).Derivation, safety and efficacy of a Marek’s disease vaccine developed from an Australian isolate of very virulent Marek’s disease virus.Australian Veterinary Journal 80: 61-66.

Wareing, M.D. and Tannock, G.A. (2002).Influenza update: vaccine development and clinical trials.Current Opinion in Pulmonary Medicine 8: 209-213 (invited review).

Wareing, M.D., Marsh, G.A. and Tannock, G.A. (2002).Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain.Vaccine 20: 2082-90.

Karpathy, R.C., Firth, G.A. and Tannock, G.A. (2003).Field evaluations of safety and efficacy of an Australian Marek’s disease vaccine.Australian Veterinary Journal (in press).

Marsh, G.A., Watson, J.M., White, W.E. and Tannock G.A. (2003).An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets.Journal of Virological Methods 107: 63-69.

Tannock, G.A., Tan, J, Mawhinney, K.A., Todd, D., O’Rourke, D. and Bagust, T.J. (2003).Adaptation of an improved blocking ELISA for the serological detection of the chicken anaemia virus using an Australian strain. Australian Veterinary Journal (in press).

Wareing, M.D., and Tannock, G.A. (2003).Route of administration is the prime determinant of IgA and Ig2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza donor strain A/Leningrad/134/17/57.Vaccine (in press).

Academic management / administration responsibilities

Unit leader in Microbiology, Department of Biotechnology and Environmental Biology, RMIT University


  • CSL Ltd since 1986
  • Steggles Pty Ltd 1981-1995
  • Roche Products, Australia, Pty Ltd 1985-88; 1997-1999-2000
  • Johnson and Johnson Ltd, Raritan, New Jersey, USA, 2000


  • Commonwealth Public Service Postgraduate Fellowship, Australian National University, Canberra (1966-69).
  • US Public Health Service Postdoctoral Fellowship, Centers for Disease Control and Prevention, Atlanta GA, USA (1975-6)
  • Guest Researcher, Centers for Disease Control and Prevention, Atlanta GA, USA (1986-7).
  • Awarded D.I. Ivanovsky Medal for distinguished contributions to virology, Russian Academy of Medical Sciences, 1999.
  • Visiting Fellow, Department of Microbiology, University of Melbourne (1990).
  • Wellcome Fellow, The Queen’s University of Belfast, Belfast, Northern Ireland 1999-2000.
  • Wellcome Fellow, National Institute for Medical Research, Mill Hill, London 2002-3.


Immunisation against influenza by the ocular route. Australian patent granted 1985.